Tirzepatide has emerged as a groundbreaking medication in the management of type 2 diabetes and chronic weight conditions, offering dual action as a GIP and GLP-1 receptor agonist that supports better glucose control and significant weight reduction when combined with diet and exercise. As we look toward 2026, interest in accessing tirzepatide injectable forms and […]